Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy.

Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T.

Neuroimage. 2006 Oct 15;33(1):218-26. Epub 2006 Aug 4.

PMID:
16889985
2.

Cerebral glucose metabolism associated with a fear network in panic disorder.

Sakai Y, Kumano H, Nishikawa M, Sakano Y, Kaiya H, Imabayashi E, Ohnishi T, Matsuda H, Yasuda A, Sato A, Diksic M, Kuboki T.

Neuroreport. 2005 Jun 21;16(9):927-31. Erratum in: Neuroreport. 2005 Aug 1;16(11):1251.

PMID:
15931063
3.

The change of regional brain metabolism (18FDG PET) in panic disorder during the treatment with cognitive behavioral therapy or antidepressants.

Prasko J, Horácek J, Záleský R, Kopecek M, Novák T, Pasková B, Skrdlantová L, Belohlávek O, Höschl C.

Neuro Endocrinol Lett. 2004 Oct;25(5):340-8.

PMID:
15580167
4.

Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia.

Lueken U, Straube B, Konrad C, Wittchen HU, Ströhle A, Wittmann A, Pfleiderer B, Uhlmann C, Arolt V, Jansen A, Kircher T.

Am J Psychiatry. 2013 Nov;170(11):1345-55. doi: 10.1176/appi.ajp.2013.12111484.

PMID:
23982225
5.

Cerebral glucose metabolism in women with panic disorder.

Bisaga A, Katz JL, Antonini A, Wright CE, Margouleff C, Gorman JM, Eidelberg D.

Am J Psychiatry. 1998 Sep;155(9):1178-83.

PMID:
9734539
6.

Regional brain metabolism and treatment response in panic disorder patients: an [18F]FDG-PET study.

Kang EH, Park JE, Lee KH, Cho YS, Kim JJ, Yu BH.

Neuropsychobiology. 2012;66(2):106-11. doi: 10.1159/000337740. Epub 2012 Jul 17.

PMID:
22814210
7.

Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders.

Nordahl TE, Stein MB, Benkelfat C, Semple WE, Andreason P, Zametkin A, Uhde TW, Cohen RM.

Biol Psychiatry. 1998 Nov 15;44(10):998-1006.

PMID:
9821564
8.

Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.

Hosokawa T, Momose T, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):243-50. doi: 10.1016/j.pnpbp.2008.11.014. Epub 2008 Dec 3.

PMID:
19100808
9.

A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.

Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD.

Arch Gen Psychiatry. 2005 Mar;62(3):290-8.

10.

Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.

Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, Koizumi H, Ohgake S, Matsuzawa D, Zhang L, Nakazato M, Iyo M.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):658-63.

PMID:
15905010
11.

What are demographic and EEG differences between responding and non-responding panic disorder patients.

Kamaradova D, Prasko J, Brunovsky M, Grambal A, Diveky T, Latalova K.

Neuro Endocrinol Lett. 2013;34(2):162-71.

PMID:
23645314
12.

Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients.

Osuch EA, Ketter TA, Kimbrell TA, George MS, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2000 Nov 15;48(10):1020-3.

PMID:
11082477
13.

Influence of personality disorder on the treatment of panic disorder--comparison study.

Prasko J, Houbová P, Novák T, Záleský R, Espa-Cervená K, Pasková B, Vyskocilová J.

Neuro Endocrinol Lett. 2005 Dec;26(6):667-74.

PMID:
16380683
14.

The effect of a combined versus a conventional cognitive-behavioral therapy on quality of life for comorbid panic disorder with agoraphobia and generalized anxiety disorder: preliminary results.

Primiano S, Marchand A, Gosselin P, Langlois F, Bouchard S, Bélanger C, Labrecque J, Dugas M, Dupuis G.

Behav Modif. 2014 Jan;38(1):3-24. doi: 10.1177/0145445513504430. Epub 2013 Sep 24.

PMID:
24068750
15.

Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.

Noda Y, Nakano Y, Lee K, Ogawa S, Kinoshita Y, Funayama T, Watanabe N, Chen J, Noguchi Y, Kataoka M, Suzuki M, Furukawa TA.

BMC Psychiatry. 2007 Dec 10;7:70.

16.

Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.

Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM.

Biol Psychiatry. 2002 Feb 1;51(3):237-52.

PMID:
11839367
17.

Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial.

King AL, Valença AM, de Melo-Neto VL, Freire RC, Mezzasalma MA, Silva AC, Nardi AE.

Sao Paulo Med J. 2011;129(5):325-34.

18.

Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.

Martinsen EW, Olsen T, Tønset E, Nyland KE, Aarre TF.

J Clin Psychiatry. 1998 Aug;59(8):437-42; quiz 443.

PMID:
9721829
19.

Healthcare utilization following cognitive-behavioral treatment for panic disorder with agoraphobia.

Roberge P, Marchand A, Reinharz D, Cloutier K, Mainguy N, Miller JM, Bégin J, Turcotte J.

Cogn Behav Ther. 2005;34(2):79-88.

PMID:
15986784
20.

Predictors and time course of response among panic disorder patients treated with cognitive-behavioral therapy.

Aaronson CJ, Shear MK, Goetz RR, Allen LB, Barlow DH, White KS, Ray S, Money R, Saksa JR, Woods SW, Gorman JM.

J Clin Psychiatry. 2008 Mar;69(3):418-24.

PMID:
18278989

Supplemental Content

Support Center